Enhancement of the interleukin 2 receptor expression on T cells by multiple B-lymphotropic lymphokines.
Three new human lymphokines, interleukin-5, BSF-2 and BSF-MP6, were shown to be active in the enhancement of the IL-2 receptor expression on T cells, although they do not stimulate growth of the T cells.
D000818:Animals; D002455:Cell Division; D002460:Cell Line; D006800:Deltaretrovirus Infections / Q000503:physiopathology; D005786:Gene Expression Regulation; D006801:Humans; D015848:Interleukin-5; D015850:Interleukin-6; D007378:Interleukins / Q000494:pharmacology*; D008222:Lymphokines / Q000494:pharmacology*; D051379:Mice; D012333:RNA, Messenger / Q000235:genetics; D011971:Receptors, Immunologic / Q000378:metabolism*; D015375:Receptors, Interleukin-2; D013601:T-Lymphocytes / Q000502:physiology*
D015848:Interleukin-5; D015850:Interleukin-6; D007378:Interleukins; D008222:Lymphokines; D012333:RNA, Messenger; D011971:Receptors, Immunologic; D015375:Receptors, Interleukin-2